An AIDS vaccine developed by a team of China scientists produced “good” results in its Phase I trial, according to the leader of the effort behind the vaccine. In this case, “good” means the vaccine performed better than other AIDS vaccines in their Phase I tests, but the scientific team, aware of the daunting Phase II and III trials still ahead, is being cautious before claiming complete success for the vaccine. Specific data from the early stage test were not released.
